Mental healthtech Psyomics raises £2.4m

Charles Wheeldon
June 21, 2022
Image from Psyomics’ website

University of Cambridge healthtech spin-off Psyomics has closed a £2.4 million funding round led by university spin-out investor Parkwalk, with participation Meltwind and BGF, along new investment from Newable Ventures, Tech Funding News has reported.

Co-founded in 2015 by Professor Sabine Bahn, head of the Cambridge Centre for Neuropsychiatric Research and Daniel Cowell, former chief operating officer of Horizon Discovery, Psyomics provides a digital mental health assessment platform Censeo. Users answer a series of questions to build a picture of their mental health symptoms and concerns, generating a report, composed of potential conditions and next-step recommendations.

Stephanie Martlew, chief executive of Psyomics, said: “The continued support from Parkwalk, Meltwind and BGF alongside new investment from Newable Ventures enables us to expand the reach of Censeo, helping more people who are struggling to find the right support for their mental health needs. We’re excited to grow our team, expand further across the NHS and demonstrate with our partners that our technology can make a substantial difference in the accuracy, consistency and efficiency of mental health assessments in a wide range of clinical settings.”

Martin Glen, investment director at Parkwalk, added: “Recent years have shown how important digital health solutions are across the board to help confront the growing challenges facing the healthcare system. Psyomics’ clinical and tech-led assessment tool will help to transform the way mental health is diagnosed and the expansion of their platform within the NHS and to individual patients is a testament to their success. We’re proud to have been working with their team from the early stages and look forward to seeing Psyomics continue to develop their platform and grow in the years to come.”

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login